BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 25792109)

  • 1. Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia.
    Magné J; Huneau JF; Borderie D; Mathé V; Bos C; Mariotti F
    Amino Acids; 2015 Sep; 47(9):1975-82. PubMed ID: 25792109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADMA and hyperhomocysteinemia.
    Dayal S; Lentz SR
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of asymmetric dimethylarginine and endothelial dysfunction.
    Böger RH
    Clin Chem Lab Med; 2003 Nov; 41(11):1467-72. PubMed ID: 14656027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
    Dayal S; Rodionov RN; Arning E; Bottiglieri T; Kimoto M; Murry DJ; Cooke JP; Faraci FM; Lentz SR
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H816-25. PubMed ID: 18567702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
    Doshi S; McDowell I; Goodfellow J; Stabler S; Boger R; Allen R; Newcombe R; Lewis M; Moat S
    Metabolism; 2005 Mar; 54(3):351-60. PubMed ID: 15736113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
    Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
    Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
    Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetric dimethylarginine (ADMA) and hyperhomocysteinemia in patients with acute myocardial infarction.
    Korandji C; Zeller M; Guilland JC; Vergely C; Sicard P; Duvillard L; Gambert P; Moreau D; Cottin Y; Rochette L
    Clin Biochem; 2007 Jan; 40(1-2):66-72. PubMed ID: 17020756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric dimethylarginine in adults with cystathionine β-synthase deficiency.
    Rocha MS; Teerlink T; Janssen MC; Kluijtmans LA; Smulders Y; Jakobs C; Tavares de Almeida I; Rivera I; Castro R; Blom HJ
    Atherosclerosis; 2012 Jun; 222(2):509-11. PubMed ID: 22484094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
    Böger RH; Lentz SR; Bode-Böger SM; Knapp HR; Haynes WG
    Clin Sci (Lond); 2001 Feb; 100(2):161-7. PubMed ID: 11171285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.
    Rodionov RN; Dayoub H; Lynch CM; Wilson KM; Stevens JW; Murry DJ; Kimoto M; Arning E; Bottiglieri T; Cooke JP; Baumbach GL; Faraci FM; Lentz SR
    Circ Res; 2010 Feb; 106(3):551-8. PubMed ID: 20019334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
    Blomster H; Puustjärvi T; Kontkanen M; Valtonen P; Teräsvirta M; Uusitalo H
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):204-9. PubMed ID: 17024436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine--an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction.
    McCarty MF
    Med Hypotheses; 2004; 63(4):699-708. PubMed ID: 15325021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
    Stühlinger MC; Oka RK; Graf EE; Schmölzer I; Upson BM; Kapoor O; Szuba A; Malinow MR; Wascher TC; Pachinger O; Cooke JP
    Circulation; 2003 Aug; 108(8):933-8. PubMed ID: 12912818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocystinemia in humans: effect of oxidative stress and proinflammatory cytokines.
    Antoniades C; Tousoulis D; Marinou K; Vasiliadou C; Tentolouris C; Bouras G; Pitsavos C; Stefanadis C
    Am J Clin Nutr; 2006 Oct; 84(4):781-8. PubMed ID: 17023704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methionine-induced homocysteinemia impairs endothelial function in hypertensives: the role of asymmetrical dimethylarginine and antioxidant vitamins.
    Tousoulis D; Bouras G; Antoniades C; Marinou K; Papageorgiou N; Miliou A; Hatzis G; Stefanadi E; Tsioufis C; Stefanadis C
    Am J Hypertens; 2011 Aug; 24(8):936-42. PubMed ID: 21490695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine.
    Stühlinger MC; Tsao PS; Her JH; Kimoto M; Balint RF; Cooke JP
    Circulation; 2001 Nov; 104(21):2569-75. PubMed ID: 11714652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.